Home › NDC Lookup › RxCUI directory › RxCUI 1235322

Diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG Topical Gel [Tact] — RxCUI 1235322

RxNorm drug concept · Semantic branded drug
RxCUI 1235322 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1235322
Official nameDiphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG Topical Gel [Tact]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTact (diphenhydramine HCl 2 % / l-menthol 1 % ) Topical Gel; Tact Cool Jelly 2 % / 1 % Topical Gel
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diphenhydramine Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It gives temporary relief of pain and itching on the skin. That includes minor burns, minor cuts or scrapes, insect bites, minor skin irritations, and rashes from poison ivy, oak o...
  • Adults and children 2 and older can apply it to the affected area no more than 3 to 4 times a day. Don't use it more often than directed. For a child under 2, check with a doctor f...
  • No. Don't use it on large areas of the body or on broken, blistered or oozing skin. Also avoid it on chicken pox or sunburn.
  • Can I put it on a large area or on blistered skin?
📖 Read our full Diphenhydramine Topical guide →

🕸️ Concept Web — How Diphenhydramine hydrochloride 0.02 MG/MG / levom... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG Topical Gel [Tact] RxCUI 1235322

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Diphenhydramine 3498
    • Levomenthol 236388
    • Diphenhydramine / levomenthol 646063
    • Diphenhydramine hydrochloride 1362
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tact 2380356
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diphenhydramine / levomenthol Topical Gel 1235316
    • Diphenhydramine hydrochloride / levomenthol Topical Gel 2646373
    • Diphenhydramine / levomenthol Topical Product 1235315
    • Diphenhydramine hydrochloride / levomenthol Topical Product 2659114
    • Diphenhydramine / levomenthol Topical Gel [Tact] 2380362
    • Diphenhydramine hydrochloride / levomenthol Topical Gel [Tact] 2654219
    • Tact Topical Product 2380359
    • Topical Gel 346286
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG Topical Gel SCD · 1235317
  • Diphenhydramine hydrochloride 0.02 MG/MG SCDC · 1049088
  • Levomenthol 0.01 MG/MG SCDC · 1235314
  • Diphenhydramine / levomenthol Topical Gel SCDF · 1235316
  • Diphenhydramine hydrochloride / levomenthol Topical Gel SCDFP · 2646373
  • Diphenhydramine / levomenthol Topical Product SCDG · 1235315
  • Diphenhydramine hydrochloride / levomenthol Topical Product SCDGP · 2659114

Brand-Name Concepts

  • Diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG [Tact] SBDC · 2380361
  • Diphenhydramine / levomenthol Topical Gel [Tact] SBDF · 2380362
  • Diphenhydramine hydrochloride / levomenthol Topical Gel [Tact] SBDFP · 2654219
  • Tact Topical Product SBDG · 2380359
  • Tact BN · 2380356

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1235322 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49873-0704-01 1 TUBE in 1 CARTON (49873-704-01) / 20 g in 1 TUBE Tact Cool Jelly Sato Pharmaceutical Co., Ltd. 1997-10-02
Observed labelers: Sato Pharmaceutical Co., Ltd. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.